Literature DB >> 11676840

Early steps of insulin action in the skin of intact rats.

F F Pelegrinelli1, A C Thirone, A L Gasparetti, E P Araujo, L A Velloso, M J Saad.   

Abstract

Insulin is an important regulator of growth and initiates its action by binding to its receptor, which undergoes tyrosyl autophosphorylation and further enhances its tyrosine kinase activity towards other intermediate molecules, including insulin receptor substrate 1, insulin receptor substrate 2, and Shc. Insulin receptor substrate proteins can dock various src-homology-2-domain-containing signaling proteins, such as the 85 kDa subunit of phosphatidylinositol 3 kinase and growth-factor-receptor-bound protein 2. The serine-threonine kinase is activated downstream to phosphatidylinositol 3 kinase. Shc protein has been shown to directly induce the association with growth-factor-receptor-bound protein 2 and downstream the activation of the mitogen-activated protein kinase. In this study we investigated insulin signal transduction pathways in skin of intact rats by immunoprecipitation and immunoblotting with specific antibodies, and also by immunohistochemistry with anti-insulin-receptor antibody. Our results showed that skin fragments clearly demonstrated the presence of insulin receptor in cell bodies of the epidermis and hair follicles and some faint staining was also detected in fibroblasts of the dermis. It was also observed that acute stimulation with insulin can induce tyrosyl phosphorylation of insulin receptor, that the insulin receptor substrates and Shc proteins serve as signaling molecules for insulin in skin of rats, and that insulin is able to induce association of insulin receptor substrate 1/phosphatidylinositol 3 kinase and Shc/growth-factor-receptor-bound protein 2 in this tissue, as well as phosphorylation of mitogen-activated protein kinase and serine-threonine kinase, demonstrating that proteins involved in early steps of insulin action are expressed in skin of intact rats and are quickly activated after insulin stimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676840     DOI: 10.1046/j.0022-202x.2001.01473.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Insulin treatment enhances pseudomonas aeruginosa biofilm formation by increasing intracellular cyclic di-GMP levels, leading to chronic wound infection and delayed wound healing.

Authors:  Qiu Wei; Zhenqiang Zhang; Jing Luo; Jinliang Kong; Yudi Ding; Yiqiang Chen; Ke Wang
Journal:  Am J Transl Res       Date:  2019-06-15       Impact factor: 4.060

2.  Topical insulin accelerates cutaneous wound healing in insulin-resistant diabetic rats.

Authors:  Tianyi Yu; Min Gao; Peilang Yang; Qing Pei; Dan Liu; Di Wang; Xiong Zhang; Yan Liu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

3.  Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice.

Authors:  Chase Watters; Katrina DeLeon; Urvish Trivedi; John A Griswold; Mark Lyte; Ken J Hampel; Matthew J Wargo; Kendra P Rumbaugh
Journal:  Med Microbiol Immunol       Date:  2012-09-25       Impact factor: 3.402

4.  A novel function of insulin in rat dermis.

Authors:  Torbjørn Nedrebø; Tine V Karlsen; Gerd S Salvesen; Rolf K Reed
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

5.  Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial.

Authors:  Maria H M Lima; Andréa M Caricilli; Lélia L de Abreu; Eliana P Araújo; Fabiana F Pelegrinelli; Ana C P Thirone; Daniela M Tsukumo; Ana Flávia M Pessoa; Marinilce F dos Santos; Maria A de Moraes; José B C Carvalheira; Lício A Velloso; Mario J A Saad
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

6.  Transdermal delivery of insulin by amidated pectin hydrogel matrix patch in streptozotocin-induced diabetic rats: effects on some selected metabolic parameters.

Authors:  Silindile I Hadebe; Phikelelani S Ngubane; Metse R Serumula; Cephas T Musabayane
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.